Robert Sanders, associate professor and chair of national security at the University of New Haven's Henry C. Lee College of Criminal Justice & Forensic Sciences, reviews the legal implications of lawsuits against China for botching that country's response in the early days of the coronavirus pandemic.
The trade war amplified calls in the U.S. and elsewhere for reducing dependence on China for strategic goods. Now, the pandemic has politicians vowing to take action.
The Food and Drug Administration had to walk back testimony by an official at a Senate hearing last week after he downplayed the scale of China’s dominance of the drug supply chain in the U.S.
Queues of tankers have formed off China’s busiest oil ports as the vessels wait to offload crude for refineries that are quickly ramping up production amid a rapid rebound in fuel demand.
Thomas O’Connor, senior director analyst with Gartner, relates the lessons that manufacturers and retailers can learn from China, which is just now emerging from lockdown due to the coronavirus pandemic.
Ron Leibman, head of the transportation, logistics and supply chain management practice at McCarter & English LLP, outlines some the legal issues and complications that are likely to arise as a result of the coronavirus pandemic.
Beijing is accelerating its bid for global leadership in key technologies, planning to pump more than a trillion dollars into the economy through the rollout of everything from wireless networks to artificial intelligence.